Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laloyaux

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 4, 2012
Thicker is better? Synthesis and evaluation of well-defined polymer brushes with controllable catalytic loadingsAntony E Fernandes, Ali Dirani, Cécile d'Haese, et al.
Epilepsy & Behavior : E&B|January 28, 2026
Does seizure duration matter? A quantitative and qualitative study on the burden and unmet needs of prolonged seizures in people living with epilepsy and their caregiversDanya Kaye, Rebecca Burns, Cédric Laloyaux, et al.
Epilepsy & Behavior : E&B|April 11, 2021
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic reviewBernhard J Steinhoff, Pavel Klein, Henrik Klitgaard, et al.
Psychiatry Research|July 13, 2024
A cross-national investigation of psychosis-like experiences in five European countries included in the E-CLECTIC study: Psychometric challenges in studying their measurementSara Siddi, Susana Ochoa, Frank Larøi, et al.
Schizophrenia Bulletin|February 5, 2019
Potential Applications of Digital Technology in Assessment, Treatment, and Self-help for HallucinationsNeil Thomas, Josef J Bless, Ben Alderson-Day, et al.
Journal of Neurology|March 4, 2024
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysisJerzy P Szaflarski, Hervé Besson, Wendyl D'Souza, et al.
Epilepsy & Behavior : E&B|July 6, 2024
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studiesEdward Faught, Hervé Besson, Wendyl D'Souza, et al.
CNS Drugs|September 8, 2023
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient RecordsVicente Villanueva, Cédric Laloyaux, Wendyl D'Souza, et al.
Schizophrenia Bulletin|February 5, 2019
A Cross-National Investigation of Hallucination-Like Experiences in 10 Countries: The E-CLECTIC StudySara Siddi, Susana Ochoa, Frank Laroi, et al.
Frontiers in Marine Science|September 20, 2019
Observational Needs for Improving Ocean and Coupled Reanalysis, S2S Prediction, and Decadal PredictionStephen G Penny, Santha Akella, Magdalena A Balmaseda, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 4, 2012
Thicker is better? Synthesis and evaluation of well-defined polymer brushes with controllable catalytic loadingsAntony E Fernandes, Ali Dirani, Cécile d'Haese, et al.
Epilepsy & Behavior : E&B|January 28, 2026
Does seizure duration matter? A quantitative and qualitative study on the burden and unmet needs of prolonged seizures in people living with epilepsy and their caregiversDanya Kaye, Rebecca Burns, Cédric Laloyaux, et al.
Epilepsy & Behavior : E&B|April 11, 2021
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic reviewBernhard J Steinhoff, Pavel Klein, Henrik Klitgaard, et al.
Psychiatry Research|July 13, 2024
A cross-national investigation of psychosis-like experiences in five European countries included in the E-CLECTIC study: Psychometric challenges in studying their measurementSara Siddi, Susana Ochoa, Frank Larøi, et al.
Schizophrenia Bulletin|February 5, 2019
Potential Applications of Digital Technology in Assessment, Treatment, and Self-help for HallucinationsNeil Thomas, Josef J Bless, Ben Alderson-Day, et al.
Journal of Neurology|March 4, 2024
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysisJerzy P Szaflarski, Hervé Besson, Wendyl D'Souza, et al.
Epilepsy & Behavior : E&B|July 6, 2024
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studiesEdward Faught, Hervé Besson, Wendyl D'Souza, et al.
CNS Drugs|September 8, 2023
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient RecordsVicente Villanueva, Cédric Laloyaux, Wendyl D'Souza, et al.
Schizophrenia Bulletin|February 5, 2019
A Cross-National Investigation of Hallucination-Like Experiences in 10 Countries: The E-CLECTIC StudySara Siddi, Susana Ochoa, Frank Laroi, et al.
Frontiers in Marine Science|September 20, 2019
Observational Needs for Improving Ocean and Coupled Reanalysis, S2S Prediction, and Decadal PredictionStephen G Penny, Santha Akella, Magdalena A Balmaseda, et al.
Pageof 7